What Is Acral Lentiginous Melanoma?

Table of Contents
View All
Table of Contents

Acral lentiginous melanoma (ALM) is a rare type of cancer that affects the pigments in a person's skin, specifically on the palms of the hands, soles of the feet, and nail beds. ALM is an aggressive form of melanoma. When detected early, it can be cured by surgically removing the lesion. However, diagnosis presents challenges, especially for those who are not diagnosed early.

This article discusses the symptoms, causes, diagnosis, and treatment of ALM.

Verywell / Michela Buttignol

Types of Acral Lentiginous Melanoma

The two primary characteristics of ALM are:

  • Location: "Acral" means "extremity" in Greek, which describes the location where this skin cancer appears (hands and feet). There's a subtype of this melanoma that is found in the nail beds, called subungual melanoma.
  • Lesion coloration: "Lentiginous" refers to the freckled pigmented appearance of the spots or lesions. They can be a different, darker shade than a person's skin. However, there are also nonpigmented or amelanotic lesions, which may appear as a red or orange color.

Prevalence of ALM

Acral lentiginous melanoma is the least common subtype of all melonomas. It's less common in White people (less than 10% of ALM cases), but it accounts for 70% of melanomas in Black people and 46% in Asian people.


There are a number of characteristic changes in the feet, hands, and nail beds associated with ALM. These include:

  • A black or brown discoloration on the palms or feet soles
  • A thick, elevated, or irregular growth on the hands or feet
  • A dark line or streak in the length of the nail that may cause damage to the nail
  • Changes in the shape or color of a mole on hands or feet

It's important to note that the lesions, lines, or growths can look similar to other conditions not caused by ALM. Your lesion will have to be closely examined by a healthcare provider to determine if it is ALM.


The cause of ALM is not clear.

There may be a genetic component associated with the development of this type of melanoma. One study found people who had ALM were more likely to have had another type of cancer or a family history of a cancer other than melanoma.

Sun exposure isn't believed to be a cause, because this type of cancer appears on parts of the body that aren't often exposed to as much UV (ultraviolet) rays from the sun.


A thorough physical examination by a healthcare provider or dermatologist (skin specialist) who is familiar with this type of cancer is a key part of the diagnostic process.

For diagnosing melanoma lesions, the ABCDE system is often used to determine if any spots on the skin may be potentially cancerous.

ABCDE System for Melanoma Lesions

The ABCDE rule outlines the following characteristics of potentially cancerous skin lesions:

  • Asymmetry: One half does not look the same as the other.
  • Border irregularity: The spot has jagged or irregular edges.
  • Color variegation: The pigment of the spot is not the same throughout and may have different colors.
  • Diameter: The spot is larger than 6 millimeters across.
  • Evolving or elevation: The spot or lesion changes in size, shape, and color over time, and it may start growing vertically (becoming raised).

Because of the challenges with correctly diagnosing ALM, providers may use a handheld device called a dermascope to closely examine any potential cancerous lesions. This tool allows the provider to see multiple parts of the skin that are not typically visible to the naked eye to assist with a diagnosis.

However, because of where the lesions are found on the body, misdiagnosis is common. For example, ALM lesions on the feet can be confused with plantar warts, ingrown toenails, blisters, calluses, benign (noncancerous) tumors, and ulceration.

Similarly, the characteristic sign of ALM in the nail bed is a brown or black line on the length of the nail. This type of line on the nail can be associated with trauma (such as having smashed a finger in a door) or even a fungal infection.

Being of a lower socioeconomic status, not having access to a dermatologist, not getting a full-body examination during primary care visits, and lacking information about ALM also are factors that contribute to the risk of misdiagnosis.


Acral lentiginous melanoma is highly treatable when diagnosed and treated early. Typical treatment is surgical removal of the lesion with the aim to remove the cancer, prevent it from coming back, and maintain the appearance of the skin.

However, if ALM is more advanced and has spread elsewhere in the body, additional treatments may be necessary. These may include chemotherapy, radiation therapy, and immunotherapy.


Survival rates are best for those with ALM when diagnosed at an early stage. However, because diagnosis is often challenging and delayed, people with advanced ALM have a poorer prognosis.

Factors that influence survival rates include the thickness of the lesion, ulceration (a break in the skin), mitotic rate (used to help find the stage of melanoma), and how far the cancer has spread in the body. Experiencing a recurrence of the lesion is 2 to 5 times more common than other types of melanoma.


Acral lentiginous melanoma is rare type of skin cancer. It primarily affects the hands, feet, and nail beds. It is more common in Black people and Asian people. Misdiagnosis can be common, but ALM can be treated successfully with surgery if diagnosed early.

A Word From Verywell

Because ALM can be challenging to diagnose, it's important to be familiar with how your body looks so you can notice changes—like a new growth or mole—that are worth investigating. Identifying any potentially cancerous spots early with the help of a healthcare provider or dermatologist can increase the chances of early treatment and a positive prognosis. While a diagnosis of ALM can be scary, effective treatment is available when caught early.

8 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. National Cancer Institute. SEER modules: types of melanoma.

  2. Huang K, Fan J, Misra S. Acral lentiginous melanoma: incidence and survival in the united states, 2006-2015, an analysis of the seer registryJournal of Surgical Research. 2020;251:329-339. doi:10.1016/j.jss.2020.02.010

  3. AIM at Melanoma Foundation. Acral lentiginous melanoma.

  4. Memorial Sloan Kettering Cancer Center. Acral letiginous melanoma.

  5. Csányi I, Houshmand N, Szűcs M, et al. Acral lentiginous melanoma: a single-centre retrospective review of four decades in East-Central EuropeJournal of the European Academy of Dermatology and Venereology. 2020;34(9):2004-2010. doi:10.1111/jdv16227

  6. Basurto-Lozada P, Molina-Aguilar C, Castaneda-Garcia C, et al. Acral lentiginous melanoma: Basic facts, biological characteristics and research perspectives of an understudied diseasePigment Cell & Melanoma Research. 2021;34(1):59-71. doi:10.1111/pcmr.12885

  7. Ward WH, Lambreton F, Goel N, Yu JQ, Farma JM. Clinical presentation and staging of melanoma. In: Ward WH, Farma JM, eds. Cutaneous Melanoma: Etiology and Therapy. Codon Publications; 2017. doi:10.15586/codon.cutaneousmelanoma.2017.ch6

  8. Bristow IR, de Berker DA. Development of a practical guide for the early recognition for malignant melanoma of the foot and nail unitJ Foot Ankle Res. 2010;3(1):22. doi:10.1186/1757-1146-3-22

By Katie Wilkinson, MPH, MCHES
Katie Wilkinson is a public health professional with more than 10 years of experience supporting the health and well-being of people in the university setting. Her health literacy efforts have spanned many mediums in her professional career: from brochures and handouts to blogs, social media, and web content.